New Emerging Psychoactive Substances (NPS): Focus on Synthetic Opioids and "Today's" Heroin
Wednesday, March 6, 2019
Location:Online Educational Webinar
New Emerging Psychoactive Substances (NPS): Focus on Synthetic Opioids and "Today's" Heroin Wednesday, March 6, 2019 | 1:00 p.m. ET, 12:00 p.m. CT The purpose of this educational lecture is to discuss current trends in NPS and issues surrounding new and emerging products. Over the last 8 years, these substances have become commonplace and most recently, illicit fentanyl, fentanyl analogs, heroin mixtures and other combinations have intensified overdose death rates in particular regions of the United States. As this trend continues, the DEA, local law enforcement, and educators have been challenged to continual assess the ever-changing landscape of these synthetic opioids and to collaborate in raising awareness in the community. This session will review the current trends in synthetic opioids, heroin sourcing, and admixtures thereof. Prevalence rates will be discussed in order to separate fact from “fiction”. In most instances, geography dictates the “flavor-of-the-week” so time for an open discussion and information sharing will be provided. As new products are emerging daily, efforts to stay current remain a challenge both scientifically and legally. As a result of this presentation, attendees will be able to understand: a) Illicit fentanyl, fentanyl analogues, and current trends b) Regional differences of products and trafficking distribution throughout the United States c) Changes in the heroin market, challenges, and current surge in stimulant use About the Speaker: Lisa Marzilli, PharmD Lisa Marzilli holds a Doctorate of Pharmacy Degree and a Bachelor of Science in Pharmacy from the University of Rhode Island, is a diabetes educator, and an adjunct professor at the University of Rhode Island. She has worked in the home infusion/oncology industry and community pharmacy since 1989, focusing primarily on outpatient educational services and wellness programs in disease-state-management. In 2009, she began working at Dominion Diagnostics, initially focusing on medication monitoring in pain management and addiction recovery, and then continued into clinical research and education. She speaks at many National Symposiums on various topics such as New Psychoactive Substances, Basic Pharmacology/Pharmacokinetics, Neurobiology of Addiction, Mindfulness and Yoga in Addiction Recovery/Behavioral Change, and has been awarded multiple honors and distinctions. In March 2015, she began working with several Rhode Island physicians and provides medication therapy management (MTM) services to patients, works collaboratively with nurse care managers, physicians, mid-level providers, and office staff as part of the Patient-Centered Medical Home (PCMH) model of care. She is also a certified yoga teacher (RYT) and began her studies in 2002 at The White Lotus Foundation in Santa Barbara. She has continued her studies in both the philosophy and physical practice of yoga. Lisa teaches weekly classes in Providence and Peacedale, Rhode Island.